Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Clin Chim Acta. 2019 May;492:50-56. doi: 10.1016/j.cca.2019.02.007. Epub 2019 Feb 11.
To determine the predictive value of preoperative lymphocyte-to-monocyte ratio (LMR) for pathological and survival outcomes in upper tract urothelial carcinoma (UTUC) after radical nephroureterectomy (RNU).
This retrospective study included 704 UTUC patients between 2008 and 2017. We used a cutoff LMR of 3.6 to evaluate its relationship with oncological outcomes after RNU, using the Kaplan-Meier method and logistic regression models.
During median follow-up of 39 months, decreased preoperative LMR was an independent predictor of poor pathological outcomes. Kaplan-Meier analysis revealed that patients with low LMR (<3.6) had poor cancer-specific survival (CSS), recurrence-free survival (RFS), and overall survival (OS); this prognostic value was ascertained for patients with high pathological grade and more advanced stage UTUC, but not for patients with low pathological features. Multivariate Cox proportional hazards model revealed that low LMR was an independent predictor of poor CSS, RFS and OS [hazard ratio (HR) = 1.42, P = 0.02; HR = 1.39, P = 0.008; HR = 1.38, P = 0.017, respectively].
Preoperative low LMR was an independent predictor of poor pathological and oncological outcomes of UTUC after RNU. Subgroup analysis confirmed that the prognostic value of LMR was confined to patients with a high pathological grade and more advanced stage tumor.
确定根治性肾输尿管切除术(RNU)后术前淋巴细胞与单核细胞比值(LMR)对肾盂尿路上皮癌(UTUC)病理和生存结果的预测价值。
本回顾性研究纳入 2008 年至 2017 年间 704 例 UTUC 患者。我们使用 LMR 截断值 3.6 来评估其与 RNU 后肿瘤学结果的关系,采用 Kaplan-Meier 方法和逻辑回归模型。
在中位数 39 个月的随访期间,术前 LMR 降低是病理结果不良的独立预测因子。Kaplan-Meier 分析显示,LMR 较低(<3.6)的患者癌症特异性生存(CSS)、无复发生存(RFS)和总体生存(OS)较差;这一预后价值在高病理分级和更晚期 UTUC 患者中得到证实,但在低病理特征患者中未得到证实。多变量 Cox 比例风险模型显示,LMR 较低是 CSS、RFS 和 OS 不良的独立预测因子[风险比(HR)=1.42,P=0.02;HR=1.39,P=0.008;HR=1.38,P=0.017]。
术前低 LMR 是 RNU 后 UTUC 病理和肿瘤学结果不良的独立预测因子。亚组分析证实,LMR 的预后价值仅限于高病理分级和更晚期肿瘤患者。